Repeated switches between reference product etanercept and biosimilar do not affect disease activity or retention rate of etanercept over 24 months - a cohort study with historical controls. [electronic resource]

By: Contributor(s): Producer: 20190909Description: 529-530 p. digitalISSN:
  • 1778-7254
Subject(s): Online resources: In: Joint bone spine vol. 86
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Comment

There are no comments on this title.

to post a comment.